|
|
On June 30, 2009, Foreign Affairs and International Trade Canada (DFAIT) conducted a stakeholder consultation on the Anti-Counterfeiting Trade Agreement (ACTA), as it pertained to counterfeit and substandard medicines. The purpose of the consulation was to continue discussing the issues related to counterfeit and substandard medicines, which were raised at the previous consultation on April 6, 2009. A range of interested stakeholders were in attendance, including representatives from academia, industry, and non-governmental organizations. The roundtable was chaired by Canada’s ACTA chief negotiator Mr. Douglas George, Director, Intellectual Property, at DFAIT. In addition, government representatives from Industry Canada, Canada Border Services Agency (CBSA), Royal Canadian Mounted Police (RCMP), Health Canada, and Public Safety Canada also participated.
|